1. Home
  2. VSAT vs DAWN Comparison

VSAT vs DAWN Comparison

Compare VSAT & DAWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VSAT
  • DAWN
  • Stock Information
  • Founded
  • VSAT 1986
  • DAWN 2018
  • Country
  • VSAT United States
  • DAWN United States
  • Employees
  • VSAT N/A
  • DAWN 174
  • Industry
  • VSAT Radio And Television Broadcasting And Communications Equipment
  • DAWN Biotechnology: Pharmaceutical Preparations
  • Sector
  • VSAT Technology
  • DAWN Health Care
  • Exchange
  • VSAT Nasdaq
  • DAWN Nasdaq
  • Market Cap
  • VSAT 1.1B
  • DAWN 1.3B
  • IPO Year
  • VSAT 1996
  • DAWN 2021
  • Fundamental
  • Price
  • VSAT $9.34
  • DAWN $12.60
  • Analyst Decision
  • VSAT Buy
  • DAWN Strong Buy
  • Analyst Count
  • VSAT 7
  • DAWN 7
  • Target Price
  • VSAT $19.00
  • DAWN $36.17
  • AVG Volume (30 Days)
  • VSAT 3.4M
  • DAWN 898.1K
  • Earning Date
  • VSAT 02-04-2025
  • DAWN 10-30-2024
  • Dividend Yield
  • VSAT N/A
  • DAWN N/A
  • EPS Growth
  • VSAT N/A
  • DAWN N/A
  • EPS
  • VSAT N/A
  • DAWN N/A
  • Revenue
  • VSAT $4,527,274,000.00
  • DAWN $101,953,000.00
  • Revenue This Year
  • VSAT $7.71
  • DAWN N/A
  • Revenue Next Year
  • VSAT $1.73
  • DAWN $36.10
  • P/E Ratio
  • VSAT N/A
  • DAWN N/A
  • Revenue Growth
  • VSAT 36.25
  • DAWN N/A
  • 52 Week Low
  • VSAT $6.69
  • DAWN $11.94
  • 52 Week High
  • VSAT $29.11
  • DAWN $18.07
  • Technical
  • Relative Strength Index (RSI)
  • VSAT 49.19
  • DAWN 33.88
  • Support Level
  • VSAT $8.95
  • DAWN $12.42
  • Resistance Level
  • VSAT $9.76
  • DAWN $12.95
  • Average True Range (ATR)
  • VSAT 0.76
  • DAWN 0.48
  • MACD
  • VSAT 0.07
  • DAWN -0.08
  • Stochastic Oscillator
  • VSAT 34.97
  • DAWN 6.13

About VSAT ViaSat Inc.

Viasat Inc provides bandwidth technologies and services in three segments: satellite services: which provides satellite-based high-speed broadband services to consumers, enterprises, and commercial airlines; commercial networks: which develops end-to-end communication and connectivity systems; and government systems: which produces network-centric Internet Protocol-based secure government communication systems. A large majority of the firm's revenue is generated in the United States, it also has its presence in non U.S. countries.

About DAWN Day One Biopharmaceuticals Inc.

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, kinase inhibitor.

Share on Social Networks: